Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionNemes Rush Group LLC
Latest Disclosed Ownership106 shares
Latest Disclosed Value $ 3,883
Nemes Rush Group LLC reports 51.38% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On April 21, 2026 - Nemes Rush Group LLC filed a 13F-HR form disclosing ownership of 106 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $3,344 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 218 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -51.38% during the quarter. The current value of the position is $3,797 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 106 -112 -51.38 4 -72.73 0.0004
2026-02-11 2025-12-31 13F NOVO-NORDISK A S ADR ADR 670100205 218 55 33.74 11 22.22 0.0010
2025-11-13 2025-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 163 -17,961 -99.10 9 -99.28 0.0009
2025-08-12 2025-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 18,124 -78,992 -81.34 1,251 -81.46 0.1362
2025-05-07 2025-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 97,116 13,951 16.78 6,744 -5.73 0.8514
2025-02-12 2024-12-31 13F NOVO-NORDISK A S ADR ADR 670100205 83,165 -10,198 -10.92 7,154 -40.33 0.8842
2024-11-13 2024-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 93,363 -6,915 -6.90 11,988 -16.25 1.7401
2024-08-15 2024-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 100,278 6,114 6.49 14,314 18.39 1.9655
2024-05-15 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 94,164 93,708 20,550.00 12,091 25,623.40 1.7309
2024-02-09 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 456 27 6.29 47 20.51 0.0076
2023-11-09 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 429 168 64.37 39 -7.14 0.0071
2023-08-02 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 261 261 42 0.0074
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.